Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants

IntroductionPrecise screening and discriminating of prostatic hyperplasia (PH) could avoid unnecessary biopsy and overdiagnosis. However, the metabolic pattern of patients with prostatic hyperplasia in Chinese population is rarely reported.MethodsUrine samples of Chinese participants with prostate c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chenye Tang, Xiao Guo, Qian Zou, Xinghao Wang, Jian Sheng, Dan Shen, Chun Sun, Shuo Li, Ruilin Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Oncology
Subjects:	prostatic hyperplasia prostate cancer urinary metabolomics discriminant biomarkers untargeted metabolomics
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1604169/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
by: O.O. Sherstyuk, et al.
Published: (2022-08-01)

Prostatic Artery Embolization for Benign Prostatic Hyperplasia—A Primer for Interventional Radiologists
by: Tiago Bilhim, et al.
Published: (2021-07-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

The Integral Role and Clinical Significance of Metabolic Profiling in Prostate Cancer: A Narrative Review
by: Valentin Nikolaevich Pavlov, et al.
Published: (2024-07-01)

Urinary dysfunction in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia
by: S. Kh. Al-Shukri, et al.
Published: (2017-12-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

Benign Prostatic Hyperplasia Treated Entirely by Unilateral Prostate Artery Embolization
by: Mohamed Shaker, et al.
Published: (2020-01-01)

Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study
by: Jules Pouchot, et al.
Published: (2024-12-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)

Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01)

Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01)

Nocturia and benign prostatic hyperplasia
by: Laketić Darko, et al.
Published: (2008-01-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

OPTIMIZATION OF TREATMENT AND PROGNOSTIC APPROACHES TO BENIGN PROSTATIC HYPERPLASIA COMPLICATIONS
by: S. M. Pikalov, et al.
Published: (2020-11-01)

Clinical portrait of an "ordinary" patient with benign prostatic hyperplasia and the efficacy of treating lower urinary tract symptoms
by: V. L. Medvedev, et al.
Published: (2023-04-01)

Possibilities of Therapeutic and Prophylactic Tactics in Management of Benign Prostatic Hyperplasia in Tuberculosis Patients
by: Z. R. Rashidov, et al.
Published: (2021-08-01)

Bladder drainage methods for acute urinary retention due to benign prostatic hyperplasia: patient-preference analysis
by: A. I. Volnukhin, et al.
Published: (2024-09-01)

Benign prostatic hyperplasia and periodontitis
by: YANG Shisong, et al.
Published: (2024-03-01)

A NEW PARADIGM IN TREATMENT OF CHRONIC PROSTATITIS AS PREVENTION OF DEVELOPMENT OF PROSTATIC HYPERPLASIA
by: Y. G. Alyaev, et al.
Published: (2012-09-01)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2021-07-01)

National trends of surgery for benign prostatic hyperplasia in Finland
by: Alisa Salmivalli, et al.
Published: (2024-04-01)

Management of Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia During and After COVID-19
by: Dean Elterman, et al.
Published: (2021-11-01)

Male sexuality and the risk of developing benign prostatic hyperplasia and prostate cancer: is there a connection?
by: M. I. Kogan, et al.
Published: (2025-07-01)

Impact of benign prostatic hyperplasia surgical treatment on voiding and urinary bladder filling symptoms
by: Milićević Snježana, et al.
Published: (2010-01-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

CORRELATION OF STORAGE SYMPTOMS OR OVERACTIVE BLADDER SYMPTOMS POST TRANSURETHRAL RESECTION OF THE PROSTATE WITH THE DURATION OF CATHETER USE IN A PATIENT WITH URINARY RETENTION DUE TO BENIGN PROSTATE HYPERPLASIA
by: Alfindy Perdinan, et al.
Published: (2025-05-01)

Prevalence of benign prostatic hyperplasia and prostrate cancer among suburban residents in Southern Nigeria
by: Ugochukwu Esomonu, et al.
Published: (2024-12-01)

Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts
by: Cheng-Ling Lee, et al.
Published: (2017-01-01)

Negative impact of benign prostatic hyperplasia on fertility in dogs–a mini-review
by: Anna Domosławska-Wyderska, et al.
Published: (2025-05-01)

MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
by: Z. M. Akhokhov, et al.
Published: (2023-10-01)

Comprehensive Review of COVID-19 on Benign Prostate Hyperplasia Patient Symptoms
by: Joongwon Choi, et al.
Published: (2022-08-01)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
by: Eric H. Kim, et al.
Published: (2018-01-01)

Percutaneous cystolithotripsy for patients with benign prostatic hyperplasia
by: M. E. Topuzov, et al.
Published: (2021-12-01)

Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care, Port Harcourt, Nigeria
by: A.A. Bock-Oruma, et al.
Published: (2013-10-01)

Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01)

Prostatic artery embolization in treatment of benign prostatic hyperplasia: outcome and efficacy in medium-sized compared to large prostates
by: Noha Elghitany, et al.
Published: (2025-06-01)

Targeted and Untargeted Urinary Metabolomics in Exercise Science: A Systematic Review
by: Zi-Xiao Yu, et al.
Published: (2025-05-01)

Diagnostic Efficacy of grey-zone Serum Prostate Specific Antigen level in patients with Benign Prostatic Hyperplasia and Prostate Carcinoma
by: Syed Atif Hussain, et al.
Published: (2025-01-01)

Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project
by: Andrea Cocci, et al.
Published: (2024-04-01)

Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
by: Taofiq Olayinka Mohammed, et al.
Published: (2024-12-01)